Table 4: Virulence profiles associated with ESBLs and non-ESBLs producing K. pneumoniae isolates.

Virulence profilesESBLs producing isolates number (%)Non-ESBLs producing isolates number (%)

Biofilm-haemagglutination-BssS-fimH11 (22%)12 (24%)
Biofilm-haemagglutination-hypermucoviscosity-BssS-fimH-iss-iucA1 (2%)1 (2%)
Biofilm-haemagglutination-BssS-fimH-iss6 (12%)1 (2%)
Biofilm-serum resistant-haemagglutination-BssS-fimH7 (14%)1 (2%)
Biofilm-serum resistant-haemagglutination-BssS-fimH-iss14 (28%)3 (6%)
Biofilm-BssS-fimH1 (2%)1 (2%)
Biofilm-serum resistant-haemagglutination-lipase-BssS-fimH2 (4%)0 (0%)
Biofilm-serum resistant-haemagglutination-BssS-fimH-iss-iucA3 (6%)0 (0%)
Biofilm-serum resistant-haemagglutination-lipase-α-hemolysis-BssS-fimH1 (2%)0 (0%)
Biofilm-serum resistant-haemagglutination-BssS-fimH-iucA1 (2%)0 (0%)
BssS-fimH1 (2%)0 (0%)
Biofilm-serum resistant-haemagglutination-hypermucoviscosity-BssS-fimH-iss-iucA1 (2%)0 (0%)
Biofilm-haemagglutination-gelatinase-BssS-fimH1 (2%)1 (2%)
Hypermucoviscosity-BssS-fimH0 (0%)2 (4%)
Biofilm-haemagglutination-hypermucoviscosity-BssS-fimH0 (0%)18 (36%)
Biofilm-haemagglutination-hypermucoviscosity-α-hemolysis-BssS-fimH0 (0%)1 (2%)
Biofilm-serum resistant-haemagglutination-hypermucoviscosity-BssS-fimH-iss-iucA0 (0%)1 (2%)
Biofilm-serum resistant-haemagglutination-lipase-α-hemolysis-BssS-fimH-iss0 (0%)1 (2%)
Biofilm-haemagglutination-hypermucoviscosity-gelatinase-BssS-fimH0 (0%)1 (2%)
Biofilm-serum resistant-haemagglutination-hypermucoviscosity-BssS-fimH-iss0 (0%)2 (4%)
Biofilm-haemagglutination-hypermucoviscosity-lipase-BssS-fimH-iss-iucA0 (0%)1 (2%)
Biofilm-serum resistant-haemagglutination-hypermucoviscosity-lipase-BssS-fimH0 (0%)2 (4%)
Biofilm-serum resistant-haemagglutination-hypermucoviscosity-lipase-BssS-fimH-iss0 (0%)1 (2%)

Total50 (100%)50 (100%)